Eric Ende
Chairman at MATINAS BIOPHARMA HOLDINGS, INC.
Net worth: 5 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roelof Rongen | M | 59 |
Matinas BioPharma, Inc.
| 13 years |
| Jerome Jabbour | M | 50 |
Ende Biomedical Consulting Group, Inc.
 Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | 11 years |
| Herbert Conrad | M | 91 | 11 years | |
| Gregory Divis | M | 57 | 7 years | |
| Todd Branning | M | 54 | 2 years | |
| Kathryn Corzo | F | 63 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Jerad G. Seurer | M | - | 7 years | |
| Stefano Ferrari | M | 55 |
Matinas BioPharma, Inc.
| 12 years |
| Geoffrey Glass | M | 50 | 6 years | |
| David Mims | M | 60 | 5 years | |
| George Bobotas | M | 76 |
Matinas BioPharma, Inc.
| 13 years |
| Matthew Wikler | M | 74 | 6 years | |
| Mark McCamish | M | 72 | 5 years | |
| Theresa Matkovits | M | 56 | 6 years | |
| James Scibetta | M | 59 | 11 years | |
| Linda Palczuk | F | 62 | 6 years | |
| Natasha Giordano | F | 62 | 4 years | |
| Abdel A. Fawzy | M | 73 |
Matinas BioPharma, Inc.
| 13 years |
| Peter Thornton | M | 59 | 7 years | |
| Hui Liu | M | 56 | 4 years | |
| Angela Woods | F | - | 3 years | |
| Denise Strauss | F | - | 3 years | |
| Keith Kucinski | M | 55 | 5 years | |
| Rangarajan Sundaram | M | 62 |
The Leonard N Stern School of Business
| 28 years |
| Stephen G. Ryan | M | 65 |
The Leonard N Stern School of Business
| 29 years |
| Jason Vaughn | M | - | 5 years | |
| Richard Kim | M | 54 | 3 years | |
| Jennifer Gudeman | M | - | 4 years | |
| Maghsoud Dariani | M | - |
Mesa Therapeutics, Inc.
| - |
| James Ferguson | M | 70 | 5 years | |
| Thomas Hoover | M | 55 | 3 years | |
| Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 years |
| Thomas McHugh | M | 59 | 5 years | |
| Steven R. Goldstein | M | 73 |
New York University
| 29 years |
| Scott Macke | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Robert Baker | M | 69 | 14 years | |
| Michael F. Kanan | M | 61 | 4 years | |
| Andrey Valentin Krakovsky | M | - |
New York University
| - |
| Michael Shannon Anderson | M | 75 | 7 years | |
| Craig R. Stapleton | M | 79 | 8 years | |
| Nicole S. Williams | F | 79 | 12 years | |
| Patrick Fabbio | M | 56 | 5 years | |
| Karen Ferrante | M | 66 | 6 years | |
| Richard P. Prestegaard | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
| Michael B. Weiss | M | - |
Emory University
| 4 years |
| Pat LePore | M | 69 | 3 years | |
| Glenn Perillo | M | - |
The Leonard N Stern School of Business
| 5 years |
| Pat M. Patalino | M | - |
New York University
| 3 years |
| Thomas Lee | M | - |
The Leonard N Stern School of Business
| 8 years |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Sok-Ho Jung | M | 59 |
New York University
| 6 years |
| Eitan Leger | M | - |
New York University
| 11 years |
| Jon Solodar | M | - |
Emory University
New York University
| 7 years |
| Gary Gaglione | M | 72 | 5 years | |
| Geoffrey Bedrosian | M | 58 |
New York University
| - |
| Dhiren D'silva | M | - | 4 years | |
| Lauren Stival | F | - | 2 years | |
| Kevin McNally | M | 55 |
The Leonard N Stern School of Business
New York University
| 3 years |
| Dominick DiPaolo | M | 49 | 1 years | |
| Claudia Maria Amelia Copper Fort | F | 56 |
New York University
| 5 years |
| Phillandas T. Thompson | M | 50 | 7 years | |
| John Calaba | M | - |
New York University
| 13 years |
| Mary Heino | F | 64 | - | |
| Ann MacDougall | F | 70 | 1 years | |
| Lewis McKay Johnson | M | 54 |
Emory University
| 4 years |
| Jonathan Isaac Dubroff | M | - |
The Leonard N Stern School of Business
| 8 years |
| Nicolo Antonio Celentano | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
| Susan Potto | F | - |
Emory University
New York University
| 7 years |
| David Scheinberg | M | 68 | 25 years | |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Bradley Campbell | M | 48 | 4 years | |
| Ralph J. Divino | M | - |
New York University
| 4 years |
| Baylor A. Lancaster-Samuel | F | - |
New York University
| 4 years |
| Mark Todtfeld | M | - |
Emory University
The Leonard N Stern School of Business
| 7 years |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Damian Georgino | M | 63 |
Emory University
| 3 years |
| Richard S. Egosi | M | 61 |
Emory University
| 5 years |
| William Mann | M | 63 | 2 years | |
| Giovanni Caruso | M | - |
New York University
| 7 years |
| Mark Irvin Allen | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
| Herb Chen | M | - |
New York University
| 4 years |
| David Moran | M | - |
New York University
| 2 years |
| William H Haemmerle | M | - |
New York University
| 2 years |
| Steinthal Tom | M | - |
New York University
| 4 years |
| Sam Nevin | M | - |
New York University
| 3 years |
| Kan Zhou | M | - |
New York University
| 6 years |
| David Park | M | - |
New York University
| 4 years |
| Kim Tracy Nordmo | F | - |
New York University
| 2 years |
| Wallace Enman | M | - |
New York University
| 4 years |
| Kam Chang | M | - |
New York University
| 4 years |
| Brian P. Donlin | M | - |
New York University
| 4 years |
| Seth Rosenfield | M | - |
New York University
| 3 years |
| Xuan Zhang | M | 49 |
New York University
| 4 years |
| Greg Gorelik | M | - |
New York University
| 4 years |
| Caio Ibrahim David | M | 56 |
New York University
| 2 years |
| Romas Garbaliauskas | M | - |
New York University
| 1 years |
| Jürg Roland Greter | M | - |
New York University
| 3 years |
| Steven Grin | M | - |
New York University
| 4 years |
| Ophir Shahaf | M | 57 |
New York University
| 2 years |
| Eric Greenspan | M | - |
New York University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.00% |
| Ireland | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Ende
- Personal Network
